Acepodia, Inc. (TPEX:6976)
15.30
-0.55 (-3.47%)
Aug 15, 2025, 2:58 PM CST
Acepodia Revenue
Acepodia had revenue of 116.00K TWD in the half year ending December 31, 2024. This brings the company's revenue in the last twelve months to 301.00K, down -98.22% year-over-year. In the year 2024, Acepodia had annual revenue of 427.00K, down -97.43%.
Revenue (ttm)
301.00K
Revenue Growth
-98.22%
P/S Ratio
29,551.73
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.90B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 427.00K | -16.17M | -97.43% |
Dec 31, 2023 | 16.59M | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lotus Pharmaceutical | 19.12B |
Oneness Biotech | 112.57M |
Polaris Group | 87.67M |
Lumosa Therapeutics | 37.25M |
Center Laboratories | 1.63B |